Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Torrent Pharmaceuticals Debt & Borrowing

Torrent Pharmaceuticals Limited confirmed the full utilization of proceeds from its issued Commercial Papers for the quarter ending March 31, 2026. This filing adheres to SEBI Master Circular requirements regarding debt instruments.

Source

NSE filing, NSE: TORNTPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Torrent Pharmaceuticals Ltd: key numbers

Share price
₹4,557.00
Market cap
₹1,73,334 Cr
Revenue (annual)
₹13,980 Cr
Net profit (annual)
₹2,163 Cr
P/E (TTM)
81.6×Sector 46.1×
Promoter holding
60.78%-7.53% QoQ
FII holding
17.22%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Torrent Pharmaceuticals Ltd

All →

Other debt & borrowing announcements

All →